Reed E, Latourelle J, Bockholt J, Bregu J, Smock J, Paulsen J, et al. MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study. Neurology. 2018;90:e264-e272 pubmed publisher
..The identification of potential biomarkers in the disease prodrome may prove useful in evaluating treatments that may postpone disease onset. NCT00051324. ..
Myers R. Huntington's disease genetics. NeuroRx. 2004;1:255-62 pubmed
..Testing is widely available and much experience has been gained with protocols that assist the individual in making an informed choice about test options, and minimize the occurrence of adverse emotional outcomes. ..
Hoss A, Labadorf A, Latourelle J, Kartha V, Hadzi T, Gusella J, et al. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement. BMC Med Genomics. 2015;8:10 pubmed publisher
Dumitriu A, Golji J, Labadorf A, Gao B, Beach T, Myers R, et al. Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease. BMC Med Genomics. 2016;9:5 pubmed publisher
..Combining multiple genome-wide platforms offers novel insights into the pathological processes responsible for this disease by identifying pathways implicated across methodologies. ..